Cargando…

A Tool to Quantify the Functional Impact of Oscillopsia

BACKGROUND: Individuals with bilateral vestibular hypofunction (BVH) often report symptoms of oscillopsia during walking. Existing assessments of oscillopsia are limited to descriptions of severity and symptom frequency, neither of which provides a description of functional limitations attributed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Anson, Eric R., Gimmon, Yoav, Kiemel, Tim, Jeka, John J., Carey, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862789/
https://www.ncbi.nlm.nih.gov/pubmed/29599743
http://dx.doi.org/10.3389/fneur.2018.00142
_version_ 1783308280779505664
author Anson, Eric R.
Gimmon, Yoav
Kiemel, Tim
Jeka, John J.
Carey, John P.
author_facet Anson, Eric R.
Gimmon, Yoav
Kiemel, Tim
Jeka, John J.
Carey, John P.
author_sort Anson, Eric R.
collection PubMed
description BACKGROUND: Individuals with bilateral vestibular hypofunction (BVH) often report symptoms of oscillopsia during walking. Existing assessments of oscillopsia are limited to descriptions of severity and symptom frequency, neither of which provides a description of functional limitations attributed to oscillopsia. A novel questionnaire, the Oscillopsia Functional Impact scale (OFI) was developed to describe the impact of oscillopsia on daily life activities. Questions on the OFI ask how often individuals are able to execute specific activities considered to depend on gaze stability in an effort to link functional mobility impairments to oscillopsia for individuals with vestibular loss. METHODS: Subjective reports of oscillopsia and balance confidence were recorded for 21 individuals with BVH and 48 healthy controls. Spearman correlation coefficients were calculated to determine the relationship between the OFI and oscillopsia visual analog scale (OS VAS), oscillopsia severity questionnaire (OSQ), and Activities-Specific Balance Confidence scale to demonstrate face validity. Chronbach’s α was calculated to determine internal validity for the items of the OFI. A one-way MANOVA was conducted with planned post hoc paired t-tests for group differences on all oscillopsia questionnaires using a corrected α = 0.0125. RESULTS: The OFI was highly correlated with measures of oscillopsia severity (OS VAS; r = 0.69, p < 0.001) and frequency (OSQ; r = 0.84, p < 0.001) and also with the Activities-Specific Balance Confidence scale (r = −0.84, p < 0.001). Cronbach’s α for the OFI was 0.97. Individuals with BVH scored worse on all measures of oscillopsia and balance confidence compared to healthy individuals (p’s < 0.001). CONCLUSION: The OFI appears to capture the construct of oscillopsia in the context of functional mobility. Combining with oscillopsia metrics that quantify severity and frequency allows for a more complete characterization of the impact of oscillopsia on an individual’s daily behavior. The OFI discriminated individuals with BVH from healthy individuals.
format Online
Article
Text
id pubmed-5862789
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58627892018-03-29 A Tool to Quantify the Functional Impact of Oscillopsia Anson, Eric R. Gimmon, Yoav Kiemel, Tim Jeka, John J. Carey, John P. Front Neurol Neuroscience BACKGROUND: Individuals with bilateral vestibular hypofunction (BVH) often report symptoms of oscillopsia during walking. Existing assessments of oscillopsia are limited to descriptions of severity and symptom frequency, neither of which provides a description of functional limitations attributed to oscillopsia. A novel questionnaire, the Oscillopsia Functional Impact scale (OFI) was developed to describe the impact of oscillopsia on daily life activities. Questions on the OFI ask how often individuals are able to execute specific activities considered to depend on gaze stability in an effort to link functional mobility impairments to oscillopsia for individuals with vestibular loss. METHODS: Subjective reports of oscillopsia and balance confidence were recorded for 21 individuals with BVH and 48 healthy controls. Spearman correlation coefficients were calculated to determine the relationship between the OFI and oscillopsia visual analog scale (OS VAS), oscillopsia severity questionnaire (OSQ), and Activities-Specific Balance Confidence scale to demonstrate face validity. Chronbach’s α was calculated to determine internal validity for the items of the OFI. A one-way MANOVA was conducted with planned post hoc paired t-tests for group differences on all oscillopsia questionnaires using a corrected α = 0.0125. RESULTS: The OFI was highly correlated with measures of oscillopsia severity (OS VAS; r = 0.69, p < 0.001) and frequency (OSQ; r = 0.84, p < 0.001) and also with the Activities-Specific Balance Confidence scale (r = −0.84, p < 0.001). Cronbach’s α for the OFI was 0.97. Individuals with BVH scored worse on all measures of oscillopsia and balance confidence compared to healthy individuals (p’s < 0.001). CONCLUSION: The OFI appears to capture the construct of oscillopsia in the context of functional mobility. Combining with oscillopsia metrics that quantify severity and frequency allows for a more complete characterization of the impact of oscillopsia on an individual’s daily behavior. The OFI discriminated individuals with BVH from healthy individuals. Frontiers Media S.A. 2018-03-15 /pmc/articles/PMC5862789/ /pubmed/29599743 http://dx.doi.org/10.3389/fneur.2018.00142 Text en Copyright © 2018 Anson, Gimmon, Kiemel, Jeka and Carey. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Anson, Eric R.
Gimmon, Yoav
Kiemel, Tim
Jeka, John J.
Carey, John P.
A Tool to Quantify the Functional Impact of Oscillopsia
title A Tool to Quantify the Functional Impact of Oscillopsia
title_full A Tool to Quantify the Functional Impact of Oscillopsia
title_fullStr A Tool to Quantify the Functional Impact of Oscillopsia
title_full_unstemmed A Tool to Quantify the Functional Impact of Oscillopsia
title_short A Tool to Quantify the Functional Impact of Oscillopsia
title_sort tool to quantify the functional impact of oscillopsia
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862789/
https://www.ncbi.nlm.nih.gov/pubmed/29599743
http://dx.doi.org/10.3389/fneur.2018.00142
work_keys_str_mv AT ansonericr atooltoquantifythefunctionalimpactofoscillopsia
AT gimmonyoav atooltoquantifythefunctionalimpactofoscillopsia
AT kiemeltim atooltoquantifythefunctionalimpactofoscillopsia
AT jekajohnj atooltoquantifythefunctionalimpactofoscillopsia
AT careyjohnp atooltoquantifythefunctionalimpactofoscillopsia
AT ansonericr tooltoquantifythefunctionalimpactofoscillopsia
AT gimmonyoav tooltoquantifythefunctionalimpactofoscillopsia
AT kiemeltim tooltoquantifythefunctionalimpactofoscillopsia
AT jekajohnj tooltoquantifythefunctionalimpactofoscillopsia
AT careyjohnp tooltoquantifythefunctionalimpactofoscillopsia